Holen Sie sich die Stockscreener-App
34.16
0.22%
0.035
Schlusskurs vom Vortag:
$34.12
Offen:
$34.65
24-Stunden-Volumen:
4.12M
Relative Volume:
0.43
Marktkapitalisierung:
$29.95B
Einnahmen:
$29.14B
Nettoeinkommen (Verlust:
$1.07B
KGV:
28.57
EPS:
1.1956
Netto-Cashflow:
$1.05B
1W Leistung:
-3.68%
1M Leistung:
-14.06%
6M Leistung:
-28.16%
1J Leistung:
+0.00%
1-Tages-Spanne:
$33.80
$34.94
1-Wochen-Bereich:
$33.80
$36.23
52-Wochen-Spanne:
$32.81
$50.88
Medline Inc Stock (MDLN) Company Profile
Firmenname
Medline Inc
Sektor
Telefon
847-949-3000
Adresse
3 LAKES DRIVE, NORTHFIELD
Compare MDLN vs ISRG, BDX, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDLN
Medline Inc
|
34.14 | 29.94B | 29.14B | 1.07B | 1.05B | 1.1956 |
ISRG
Intuitive Surgical Inc
|
400.31 | 138.20B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
187.11 | 49.24B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.28 | 35.55B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
229.87 | 31.73B | 5.54B | 1.52B | 1.74B | 10.37 |
Medline Inc Stock (MDLN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Fortgesetzt | Citigroup | Buy |
| 2026-02-05 | Eingeleitet | Tigress Financial | Buy |
| 2026-01-21 | Bestätigt | BTIG Research | Buy |
| 2026-01-12 | Eingeleitet | Citigroup | Buy |
| 2026-01-12 | Eingeleitet | Deutsche Bank | Hold |
| 2026-01-12 | Eingeleitet | Evercore ISI | Outperform |
| 2026-01-12 | Eingeleitet | Goldman | Buy |
| 2026-01-12 | Eingeleitet | JP Morgan | Overweight |
| 2026-01-12 | Eingeleitet | Jefferies | Buy |
| 2026-01-12 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-12 | Eingeleitet | Mizuho | Outperform |
| 2026-01-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2026-01-12 | Eingeleitet | Piper Sandler | Overweight |
| 2026-01-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2026-01-12 | Eingeleitet | Rothschild & Co Redburn | Neutral |
| 2026-01-12 | Eingeleitet | Stifel | Buy |
| 2026-01-12 | Eingeleitet | TD Cowen | Buy |
| 2026-01-12 | Eingeleitet | Truist | Buy |
| 2026-01-12 | Eingeleitet | UBS | Buy |
| 2026-01-12 | Eingeleitet | Wells Fargo | Equal Weight |
| 2026-01-12 | Eingeleitet | William Blair | Outperform |
| 2026-01-12 | Eingeleitet | Wolfe Research | Outperform |
Alle ansehen
Medline Inc Aktie (MDLN) Neueste Nachrichten
MDLN News Today | Why did Medline stock go down today? - MarketBeat
Medline stock drops over 7% after FDA cites maj... - Pluang
Medline tallies tariff refunds as Q2 sales rise 11.6% - Digital Commerce 360
Medline (NASDAQ:MDLN) Major Shareholder Sells $3,580,000.00 in Stock - MarketBeat
Medline (NASDAQ:MDLN) Major Shareholder Private Ltd Gic Sells 1,500,000 Shares of Stock - MarketBeat
GIC-tied Medline Inc. (MDLN) sells 1.6M shares at $35.80 in August 2026 - Stock Titan
Medline Inc. (MDLN) Stock Plummets 7% Amid FDA Warning Letter and Securities Law Probe - Kalkine Media
MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - Barchart.com
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of a - The National Law Review
Medline Inc. (MDLN) Shares Drop 7% After FDA Warning Letter Triggers Securities Law Investigation - kalkine.ca
Tigress Financial Adjusts Medline Price Target to $55 From $62, Maintains Buy Rating - marketscreener.com
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to - The National Law Review
MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - Morgan County Citizen
Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law ViolationsInvestors are Encouraged to Contact the Firm - The Globe and Mail
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Benzinga
Medline Inc. Class A Common Stock (NASDAQ: MDLN) Stock Price, News & Analysis - Kalkine
Medline faces securities probe after FDA cites manufacturing violations, stock drops 7%. - pluang.com
Kaplan Fox Investigates Medline Inc. Over Alleged Securities Violations Following FDA Warning Letters - kalkine.ca
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares By Investing.com - Investing.com South Africa
Hellman & Friedman funds (MDLN) report 153M Medline Class A shares in latest ownership update - Stock Titan
Tigress Financial lowers Medline stock price target on fire impact By Investing.com - Investing.com UK
Private Ltd Gic Sells 590,284 Shares of Medline (NASDAQ:MDLN) Stock - MarketBeat
Tigress Financial lowers Medline stock price target on fire impact - Investing.com
GIC Private Ltd sells $21m Medline Inc. (MDLN) shares - Investing.com
Wells Fargo & Company Cuts Medline (NASDAQ:MDLN) Price Target to $34.00 - MarketBeat
MEDLINE INC. : TD COWEN CUTS TARGET PRICE TO $45 FROM $53 - Bitget
Medline $MDLN Shares Acquired by Cetera Investment Advisers - MarketBeat
Bank of America Corp DE Lowers Holdings in Medline $MDLN - marketbeat.com
Blackstone entities (NASDAQ: MDLN) report 153.3M Medline shares, 16.5% stake - Stock Titan
Medline stock drops over 19% after FDA cites ma... - Pluang
NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm - PR Newswire
Medline Inc. (MDLN) major holder sells 2,248,612 shares, keeps large stake - Stock Titan
Kaplan Fox Notifies Investors of Medline Inc. (NASDAQ: MDLN) of an Investigation Into Potential Securities Law Violations - barchart.com
Medline Q2 2026 EPS Tops Expectations by 56.2%, Revenue Up 12% - AlphaStreet
FMR LLC discloses 5.5% Medline Inc (MDLN) Class A ownership stake - Stock Titan
Medline Inc. Stock 12‑Month Price Target Cut to $46.69, Implies 27% Upside - TradingView
Finanzdaten der Medline Inc-Aktie (MDLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
4.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):